Literature DB >> 18271913

Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorder.

Maria E Pagano1, Christine A Demeter, Jon E Faber, Joseph R Calabrese, Robert L Findling.   

Abstract

OBJECTIVES: The primary purpose of this study was to examine the extent to which the initiation of stimulant and antidepressant medication was associated with the subsequent onset of juvenile bipolar I disorder (BP I). Another aim was to investigate differences in clinical presentation between youths prescribed stimulant or antidepressant medication before and after the onset of juvenile BP I disorder.
METHODS: Youths between the ages of 5 and 17 years meeting full, unmodified DSM-IV diagnostic symptom criteria for BP were included in this study. Data regarding the age of onset of BP I, psychiatric comorbidities, and current symptoms of mania and depression were obtained. Medication history was recorded as part of the assessment interview with parents and youths.
RESULTS: Of the 245 youths with BP I, 65% (n = 160) were treated with stimulant medication; 32% (56/173) were treated after the onset of BP I, and 19% (32/173) were treated before the onset of BP I. Forty-six percent (113/245) were treated with antidepressant medication; 33% (67/206) were treated after the onset of BP I, and 3% (7/206) were treated before the onset of BP I. Patients who were treated with stimulants after the onset of BP I were significantly more likely to be younger (p < 0.0001). Patients who were treated with antidepressants before the onset of BP I were significantly more likely to be older and to have lower levels of mania on the Young Mania Rating Scale at assessment (p < 0.01).
CONCLUSIONS: Data from this retrospective case series do not support the association between initial stimulant or antidepressant use and the onset of BP I or presenting symptoms of depression or manic symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18271913      PMCID: PMC3005589          DOI: 10.1111/j.1399-5618.2007.00496.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  25 in total

1.  Difficulties in diagnosing manic disorders among children and adolescents.

Authors:  M A Bowring; M Kovacs
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-07       Impact factor: 8.829

2.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

3.  Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF.

Authors:  B Geller; K Warner; M Williams; B Zimerman
Journal:  J Affect Disord       Date:  1998-11       Impact factor: 4.839

4.  Manic symptoms in psychiatrically hospitalized children--what do they mean?

Authors:  G A Carlson; K L Kelly
Journal:  J Affect Disord       Date:  1998-11       Impact factor: 4.839

Review 5.  The psychosocial context of bipolar disorder: environmental, cognitive, and developmental risk factors.

Authors:  Lauren B Alloy; Lyn Y Abramson; Snezana Urosevic; Patricia D Walshaw; Robin Nusslock; Amy M Neeren
Journal:  Clin Psychol Rev       Date:  2005-09-06

6.  Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder.

Authors:  Robert L Findling; Nora K McNamara; Eric A Youngstrom; Robert Stansbrey; Barbara L Gracious; Michael D Reed; Joseph R Calabrese
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-05       Impact factor: 8.829

7.  Early symptoms of mania and the role of parental risk.

Authors:  Robert L Findling; Eric A Youngstrom; Nora K McNamara; Robert J Stansbrey; Christine A Demeter; Denise Bedoya; Shoshana Y Kahana; Joseph R Calabrese
Journal:  Bipolar Disord       Date:  2005-12       Impact factor: 6.744

8.  Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.

Authors:  Russell E Scheffer; Robert A Kowatch; Thomas Carmody; A John Rush
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

9.  Self-esteem deficits and suicidal tendencies among adolescents.

Authors:  J C Overholser; D M Adams; K L Lehnert; D C Brinkman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-07       Impact factor: 8.829

10.  Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder.

Authors:  Robert L Findling; Thomas W Frazier; Eric A Youngstrom; Nora K McNamara; Robert J Stansbrey; Barbara L Gracious; Michael D Reed; Christine A Demeter; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2007-05       Impact factor: 4.384

View more
  4 in total

Review 1.  Preventative strategies for early-onset bipolar disorder: towards a clinical staging model.

Authors:  Robert K McNamara; Jayasree J Nandagopal; Stephen M Strakowski; Melissa P DelBello
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

Review 2.  Antidepressants and psychostimulants in pediatric populations: is there an association with mania?

Authors:  Michelle Goldsmith; Manpreet Singh; Kiki Chang
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

3.  Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors.

Authors:  Megan F Joseph; Eric A Youngstrom; Jair C Soares
Journal:  Future Neurol       Date:  2009-01-01

Review 4.  Early-onset bipolar spectrum disorders: diagnostic issues.

Authors:  Stephanie Danner; Mary A Fristad; L Eugene Arnold; Eric A Youngstrom; Boris Birmaher; Sarah M Horwitz; Christine Demeter; Robert L Findling; Robert A Kowatch
Journal:  Clin Child Fam Psychol Rev       Date:  2009-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.